Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SV Life Sciences maintains ophthalmology focus by backing Imagen Biotech

This article was originally published in Scrip

Executive Summary

SV Life Sciences reinforced its interest in backing biotechs focusing on ophthalmology by participating in the $40 million series A round closed by Imagen Biotech, a New York-based start-up. The financing round represents the fifth investment in an ophthalmology company this year, and the ninth one in the past three years. SV Life Sciences was joined by Novo Ventures and Fidelity Biosciences.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts